BioTuesdays

XORTX names Bruce Rowlands as chairman

XORTX Therapeutics (CSE:XRX) appointed Bruce Rowlands, a director, as chairman of the board.

Mr. Rowlands has extensive experience in the life sciences industry in Canada through his long association with Lorus Therapeutics, where he acted as a
consultant, banker and senior executive during its early drug development years, and as a VP and director of investment banker, Dominick & Dominick Securities.

In a statement, Dr. Allen Davidoff, founder and CEO of XORTX, said Mr. Rowlands has been an excellent director and supporter of XORTX for several years and expanding his role with XORTX is a natural transition.

“This expanded role will permit him to bring his broad capital markets and extensive pharmaceutical industry talents to the benefit of the XORTX,” he added.

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.